• Vancomycin in Immune-Microbiota Modulation: Beyond Bacter...

  2025-09-29

  Discover how Vancomycin, a premier glycopeptide antibiotic, is shaping advanced research into bacterial resistance mechanisms, immune modulation, and microbiota dynamics. This article uniquely explores Vancomycin’s dual role as a bacterial cell wall synthesis inhibitor and a tool for dissecting immune-microbiota interactions, offering new perspectives for MRSA and Clostridium difficile infection research.

• Sildenafil Citrate: Unveiling Proteoform-Selective Pathwa...

  2025-09-28

  Discover how Sildenafil Citrate, a selective PDE5 inhibitor, advances proteoform-specific vascular research through cutting-edge native mass spectrometry and cell signaling analysis. This article uniquely explores translational applications and the integration of top-down proteomics for precision drug development.

• Sulfo-NHS-SS-Biotin Kit: Advancing Cell Surface GlycoRNA ...

  2025-09-27

  Explore how the Sulfo-NHS-SS-Biotin Kit empowers next-generation, reversible biotin labeling of cell surface glycoRNAs and RNA-binding proteins. This in-depth analysis uncovers unique strategies for dissecting extracellular interactomes, setting a new benchmark in water-soluble amine-reactive biotinylation reagent applications.

• Propidium Iodide: Precision and Pitfalls in Immune Ce

  2025-09-26

  Explore the advanced scientific utility of Propidium iodide as a PI fluorescent DNA stain for cell viability assays, apoptosis detection, and cell cycle analysis. This article uniquely examines how PI enables nuanced immune cell fate mapping and addresses experimental challenges in preeclampsia and beyond.

• TNF-alpha Recombinant Murine Protein: Unraveling Apoptosi...

  2025-09-25

  Explore how TNF-alpha recombinant murine protein advances cancer and inflammation research by dissecting apoptosis mechanisms beyond gene transcription. This article offers unique insights into TNF receptor signaling and the latest discoveries in cell death pathways.

• Pseudo-modified Uridine Triphosphate: A New Era for Perso...

  2025-09-24

  Discover how pseudo-modified uridine triphosphate (Pseudo-UTP) revolutionizes mRNA synthesis with enhanced stability and reduced immunogenicity. This article uniquely explores cutting-edge delivery platforms and future directions for personalized mRNA vaccine development.

• TMCB as a Biochemical Reagent for Protein Phase Separatio...

  2025-09-23

  Explore the utility of TMCB(CK2 and ERK8 inhibitor), a tetrabromo benzimidazole derivative, as a molecular tool for enzyme interaction and protein phase separation research. This article examines TMCB’s chemical features and its relevance in studying liquid–liquid phase separation, leveraging recent insights from SARS-CoV-2 nucleocapsid protein research.

• ABT-737: Mechanistic and Translational Implications for B...

  2025-09-22

  Explore the multifaceted applications of ABT-737, a potent BH3 mimetic and small molecule BCL-2 protein inhibitor, with emphasis on its mechanistic insights and translational significance in apoptosis induction across cancer models, including lymphoma, multiple myeloma, SCLC, and AML.

• ARCA Cy5 EGFP mRNA (5-moUTP): Illuminating mRNA Delivery ...

  2025-09-19

  Explore the unique advantages of ARCA Cy5 EGFP mRNA (5-moUTP) as a fluorescently labeled mRNA for delivery analysis and translation efficiency assays. This article delves into the roles of chemical modifications, advanced capping, and dual-fluorescence labeling in dissecting mRNA delivery and localization in mammalian cells.

• Optimizing Polyadenylation of RNA Transcripts with HyperS...

  2025-09-18

  Explore how the HyperScribe™ Poly (A) Tailing Kit streamlines the polyadenylation of RNA transcripts for enhanced mRNA stability and translation efficiency in advanced molecular biology applications.

• Exposure to B a P is an epidemiologically proven cause

  2025-03-03

  

  Exposure to B[a]P is an epidemiologically proven cause of lung cancer (Hecht, 2003; Rojas et al., 2004; Alexandrov et al., 2010), and the formation of B[a]PDE-N2-dG adducts is considered to be the critical event in lung tumorigenesis by B[a]P. On the other hand, there is evidence suggesting that the

• Kifunensine To verify whether circulating APN

  2025-03-03

  

  To verify whether circulating APN could protect cognitive function during aging, we detected the alterations in circulating adipoenctin levels in aging rats. Our results suggested that circulating APN levels reduced with age. Kawasumi et al’s study results are consistent with ours. They concluded th

• br Materials and methods br Results Bilateral microinjection

  2025-03-03

  

  Materials and methods Results Bilateral microinjections (n = 6) of 10 mM ACh (300–500 pmol) and 5 mM physostigmine (150–250 pmol) at the two selected caudal NTS sites caused within 1 min significant increases in respiratory frequency (from 54.5 ± 1.7 to 70.9 ± 4.1 breaths/min; +30.8 ± 7.0%; P 

• The structures of these compounds were

  2025-03-03

  

  The structures of these compounds were confirmed from their spectral and micro analytical data. Based on [M + H] 367, molecular formula of was established as CHON. The IR spectrum of showed Dopamine receptor agonist due to CO stretching at 1700 Cm & OH stretching at 3188 Cm indicating that compound

• A rational approach for the

  2025-03-03

  

  A rational approach for the design of new steroid compounds as possible competitive inhibitors of CYP17 include chemical modification at C17 of the enzyme's natural substrates, pregnenolone (1) and progesterone (2), introducing groups with moderate to strong dipole properties at C20, such as oxime a

14269 records 1/952 page Next 12345 下5页 Last page